Wasn't this CEO supposed to be the great savior?
Yes, and he's already worked out what is needed to get FebriDx over the line for FDA approval, hence the plan to resubmit an amended application. As long as they don't waste a lot of energy and resources on the new application.
Still early into his tenure so we'll have a while to wait and see how he can turn the ship around.
